High-performance liquid chromatographic determination of metaiodobenzylguanidine in whole blood and plasma of cancer patients

J Pharm Biomed Anal. 1994 Sep;12(9):1173-9. doi: 10.1016/0731-7085(94)e0034-x.

Abstract

An accurate and simple high-performance liquid chromatographic (HPLC) assay is presented for the quantitative determination of metaiodobenzylguanidine (MIBG) in human whole blood and plasma. The sample pretreatment involves a solid-phase extraction on Bakerbond SPE cyano columns. The HPLC system comprises a microBondapak C18 column and ammonium phosphate (pH4.0; 25 mM)-acetonitrile (80:20, v/v) as the mobile phase. Detection is performed by UV absorbance measurements at 254 nm. Linear regression with weighting factor l/chi 2 yielded the smallest sum of per cent relative concentration residuals over the concentration range of the assay (0.1-10 micrograms ml-1). MIBG levels, at the end of a 3-h infusion, in whole blood and plasma of carcinoid patients were measured and compared with the results obtained with radiodetection after addition of iodine-131-labelled MIBG.

Publication types

  • Comparative Study

MeSH terms

  • 3-Iodobenzylguanidine
  • Adult
  • Antineoplastic Agents / blood*
  • Antineoplastic Agents / pharmacokinetics
  • Carcinoid Tumor / blood*
  • Chromatography, High Pressure Liquid / methods
  • Female
  • Humans
  • Infusions, Intravenous
  • Iodobenzenes / blood*
  • Iodobenzenes / pharmacokinetics
  • Male
  • Middle Aged
  • Plasma / chemistry
  • Reproducibility of Results

Substances

  • Antineoplastic Agents
  • Iodobenzenes
  • 3-Iodobenzylguanidine